Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 11975091)

1.

[Analgesic effect of the selective noradrenaline reuptake inhibitor reboxetine].

Schüler P, Seibel K, Chevts V, Schaffler K.

Nervenarzt. 2002 Feb;73(2):149-54. German.

PMID:
11975091
2.

The effects of reboxetine on autonomic and cognitive functions in healthy volunteers.

Siepmann M, Mück-Weymann M, Joraschky P, Kirch W.

Psychopharmacology (Berl). 2001 Sep;157(2):202-7.

PMID:
11594447
3.
5.

Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.

Aragona M, Bancheri L, Perinelli D, Tarsitani L, Pizzimenti A, Conte A, Inghilleri M.

Eur J Pain. 2005 Feb;9(1):33-8.

PMID:
15629872
7.

Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance.

Schroeder C, Tank J, Boschmann M, Diedrich A, Sharma AM, Biaggioni I, Luft FC, Jordan J.

Circulation. 2002 Jan 22;105(3):347-53.

8.

Dimethindene maleate in the treatment of sunburn. A double-blind, placebo-controlled pilot study.

Schaffler K, Beckers C, Unkauf M, Kyrein HJ.

Arzneimittelforschung. 1999 Apr;49(4):374-9.

PMID:
10337458
9.

Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study.

Poyurovsky M, Isaacs I, Fuchs C, Schneidman M, Faragian S, Weizman R, Weizman A.

Am J Psychiatry. 2003 Feb;160(2):297-302.

PMID:
12562576
11.

No effect of a noradrenergic reuptake inhibitor on performance in trained cyclists.

Piacentini MF, Meeusen R, Buyse L, De Schutter G, Kempenaers F, Van Nijvel J, De Meirleir K.

Med Sci Sports Exerc. 2002 Jul;34(7):1189-93.

PMID:
12131261
12.

Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects.

Schüle C, Baghai T, Schmidbauer S, Bidlingmaier M, Strasburger CJ, Laakmann G.

Psychoneuroendocrinology. 2004 Feb;29(2):185-200.

PMID:
14604600
13.

Acute reboxetine administration increases plasma and salivary cortisol.

Hill SA, Taylor MJ, Harmer CJ, Cowen PJ.

J Psychopharmacol. 2003 Sep;17(3):273-5.

PMID:
14513918
14.

The antinociceptive properties of reboxetine in acute pain.

Schreiber S, Frishtick R, Volis I, Rubovitch V, Pick CG, Weizman R.

Eur Neuropsychopharmacol. 2009 Oct;19(10):735-9. doi: 10.1016/j.euroneuro.2009.06.004. Epub 2009 Jul 5.

PMID:
19577903
15.

Reboxetine induces similar sleep-EEG changes like SSRI's in patients with depression.

Kuenzel HE, Murck H, Held K, Ziegenbein M, Steiger A.

Pharmacopsychiatry. 2004 Sep;37(5):193-5.

PMID:
15359374
16.

Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study.

Seedat S, van Rheede van Oudtshoorn E, Muller JE, Mohr N, Stein DJ.

Int Clin Psychopharmacol. 2003 Sep;18(5):279-84.

PMID:
12920388
17.

No influence of noradrenaline manipulation on acute exercise-induced increase of brain-derived neurotrophic factor.

Goekint M, Heyman E, Roelands B, Njemini R, Bautmans I, Mets T, Meeusen R.

Med Sci Sports Exerc. 2008 Nov;40(11):1990-6. doi: 10.1249/MSS.0b013e31817eee85.

PMID:
18845978
18.
19.

Effects of flurbiprofen enantiomers on pain-related chemo-somatosensory evoked potentials in human subjects.

Lötsch J, Geisslinger G, Mohammadian P, Brune K, Kobal G.

Br J Clin Pharmacol. 1995 Oct;40(4):339-46.

20.

Effects of reboxetine, a selective norepinephrine reuptake inhibitor, on sympathetic and parasympathetic outflow to the heart: preliminary data.

Agelink MW, Ullrich H, Baumann B, Strum S, Majewski T.

Psychopharmacology (Berl). 2002 Sep;163(2):151-6. Epub 2002 Jul 19.

PMID:
12202961
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk